By analyzing differential RNA expression profiles with or without treatment with 5‐aza‐2′‐deoxycytidine, the frequency of CDO1 promoter methylation was observed with a statistically significant difference between normal and tumor tissues [17]. This evidence concerns the gene CDO1 and neoplasm.